XML 75 R62.htm IDEA: XBRL DOCUMENT
v3.8.0.1

COMMITMENTS AND CONTINGENCIES - Narrative (Details) |  |  | 9 Months Ended | 27 Months Ended |
--- | --- | --- | --- | --- | ---
Feb. 24, 2017 USD ($) | Jul. 17, 2015 USD ($) | Sep. 30, 2017 case | Oct. 26, 2017 USD ($) | Jan. 15, 2014 USD ($)
Supply Commitment, Current, Long-Term, and Above Market |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Fair value inputs, discount rate |  |  | 12.00% |  |
Indemnification period - up to fifteen months after close | Subsequent Event |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Indemnification payments received |  |  |  | $ 0 |
Indemnification payments owed |  |  |  | $ 0 |
TEI |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Number of active cases | case |  |  | 10 |  |
Indemnification policy in place |  | $ 3,000,000.0 |  |  |
TEI | Indemnification period - up to fifteen months after close |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Maximum indemnification from acquisition |  | $ 30,000,000 |  |  |
Period of indemnification |  | 15 months |  |  |
TEI | Indemnification period - up to 3 years after close |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Maximum indemnification from acquisition |  | $ 30,000,000 |  |  |
Period of indemnification |  | 3 years |  |  |
Minimum indemnification from acquisition |  | $ 20,000,000 |  |  |
TEI | Third Party Insurer |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Indemnification policy in place |  | $ 3,000,000.0 |  |  |
Confluent Surgical, Inc. |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Contingent consideration range of outcomes, value, high |  |  |  |  | $ 30,000,000
Confluent Surgical, Inc. | Contingent Consideration Liability |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Fair value inputs, discount rate |  |  | 2.20% |  |
Confluent Surgical, Inc. | Cash Consideration One |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Contingent consideration range of outcomes, value, high |  |  |  |  | 25,000,000
Confluent Surgical, Inc. | Cash Consideration Two |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Contingent consideration range of outcomes, value, high |  |  |  |  | $ 5,000,000
Derma Sciences | BioD Earnout Payments |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |
Contingent consideration range of outcomes, value, high | $ 26,500,000 |  |  |  |
Fair value inputs, discount rate | 3.00% |  |  |  |

X
- Definition Business Combination, Indemnification Assets, Period of Indemnification + References No definition available. + Details
Name: | iart_BusinessCombinationIndemnificationAssetsPeriodofIndemnification
Namespace Prefix: | iart_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (c)(3) -URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of indemnification assets (amounts to be reimbursed if and when certain assumed liabilities are paid) recognized at the acquisition date of a business combination. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition For indemnification assets recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the indemnification benefit which may be realized. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationIndemnificationAssetsRangeOfOutcomesValueHigh
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition For indemnification assets recognized in connection with a business combination, this element represents an estimate of the low-end of the potential range (undiscounted) of the indemnification benefit which may be realized. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationIndemnificationAssetsRangeOfOutcomesValueLow
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure fair value. For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb) -URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueInputsDiscountRate
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_LossContingenciesLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of pending claims pertaining to a loss contingency. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=82911808&loc=d3e14435-108349 + Details
Name: | us-gaap_LossContingencyPendingClaimsNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of receivable related to a loss contingency accrual. For example, an insurance recovery receivable. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 460 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=82913245&loc=d3e12053-110248 + Details
Name: | us-gaap_LossContingencyReceivable
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of cash inflow from the collection of receivables related to a loss contingency. + References No definition available. + Details
Name: | us-gaap_LossContingencyReceivableProceeds
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_SupplyCommitmentAxis=iart_SupplyCommitmentCurrentLongTermandAboveMarketMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementScenarioAxis=iart_IndemnificationPeriodOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iart_TEIMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementScenarioAxis=iart_IndemnificationPeriodTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=iart_ThirdPartyInsurerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iart_ConfluentSurgicalInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByLiabilityClassAxis=iart_ContingentConsiderationLiabilityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=iart_CashConsiderationOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=iart_CashConsiderationTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=iart_BioDEarnoutPaymentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |